nicardipine has been researched along with Aldosteronism in 5 studies
Nicardipine: A potent calcium channel blockader with marked vasodilator action. It has antihypertensive properties and is effective in the treatment of angina and coronary spasms without showing cardiodepressant effects. It has also been used in the treatment of asthma and enhances the action of specific antineoplastic agents.
nicardipine : A racemate comprising equimolar amounts of (R)- and (S)-nicardipine. It is a calcium channel blocker which is used to treat hypertension.
2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine substituted by a methyl, {2-[benzyl(methyl)amino]ethoxy}carbonyl, 3-nitrophenyl, methoxycarbonyl and methyl groups at positions 2, 3, 4, 5 and 6, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the study was to evaluate the effects of a dihydropyridine calcium antagonist, nicardipine (N), on blood pressure (BP) and aldosterone secretion in hypertensive patients (pt) with primary aldosteronism." | 9.06 | [Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]. ( Begasse, F; Chamontin, B; David, D; Salvador, M, 1989) |
| "Nicardipine (80 mg/day) was given orally for 12 weeks and no dietary restrictions were imposed." | 6.67 | Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism. ( Bisbocci, D; Chiandussi, L; Pinna, G; Piras, D; Rabbia, F; Veglio, F, 1990) |
| "The purpose of the study was to evaluate the effects of a dihydropyridine calcium antagonist, nicardipine (N), on blood pressure (BP) and aldosterone secretion in hypertensive patients (pt) with primary aldosteronism." | 5.06 | [Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism]. ( Begasse, F; Chamontin, B; David, D; Salvador, M, 1989) |
| "In the present study we estimated the periodic profiles and variance structure of systolic blood pressure, diastolic blood pressure, heart rate and mean arterial pressure by using an autoregressive model of power spectrum, Maximum Entropy Method (MEM) in 8 patients with primary aldosteronism, during long-term therapy with nicardipine slow release." | 3.68 | Twenty-four-hour power spectral analysis by maximum entropy method of blood pressure in primary hyperaldosteronism. ( Chiandussi, L; Melchio, R; Molino, P; Pinna, G; Rabbia, F; Torchio, C; Veglio, F, 1993) |
| "Nicardipine (80 mg/day) was given orally for 12 weeks and no dietary restrictions were imposed." | 2.67 | Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism. ( Bisbocci, D; Chiandussi, L; Pinna, G; Piras, D; Rabbia, F; Veglio, F, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Veglio, F | 2 |
| Pinna, G | 2 |
| Melchio, R | 1 |
| Rabbia, F | 2 |
| Molino, P | 1 |
| Torchio, C | 1 |
| Chiandussi, L | 2 |
| Zeng, ZP | 1 |
| Naruse, M | 1 |
| Guan, BJ | 1 |
| Naruse, K | 1 |
| Sun, ML | 1 |
| Zang, MF | 1 |
| Demura, H | 1 |
| Shi, YF | 1 |
| Bisbocci, D | 1 |
| Piras, D | 1 |
| Chamontin, B | 1 |
| Begasse, F | 1 |
| David, D | 1 |
| Salvador, M | 1 |
| Jeunemaitre, X | 1 |
| Valenta de Almeida, L | 1 |
| Sassano, P | 1 |
| Farge, D | 1 |
| Guyene, TT | 1 |
| Julien, J | 1 |
| Plouin, PF | 1 |
| Corvol, P | 1 |
2 trials available for nicardipine and Aldosteronism
| Article | Year |
|---|---|
Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism.
Topics: Administration, Oral; Adult; Aldosterone; Blood Pressure; Delayed-Action Preparations; Female; Human | 1990 |
[Effect of a calcium inhibitor, nicardipine, on aldosterone secretion in primary hyperaldosteronism].
Topics: Aged; Aldosterone; Blood Pressure; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Hypera | 1989 |
3 other studies available for nicardipine and Aldosteronism
| Article | Year |
|---|---|
Twenty-four-hour power spectral analysis by maximum entropy method of blood pressure in primary hyperaldosteronism.
Topics: Activity Cycles; Adult; Blood Pressure; Circadian Rhythm; Female; Heart Rate; Humans; Hyperaldostero | 1993 |
Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism.
Topics: Adenoma; Adrenal Cortex; Adrenal Gland Neoplasms; Adult; Aldosterone; Endothelins; Female; Humans; H | 1992 |
[Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?].
Topics: Adult; Aldosterone; Blood Pressure; Heart Rate; Humans; Hyperaldosteronism; Hypertension; Hypertensi | 1988 |